Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit TIM16 (PAM16) is a 15.1 kDa protein component of the mitochondrial inner membrane that plays an essential role in the protein import machinery. It forms part of the presequence translocase-associated motor (PAM) complex, specifically acting as a co-chaperone with Pam18 (DNAJC19) to regulate the mitochondrial Hsp70-mediated ATP-driven import of proteins with N-terminal targeting sequences across the inner mitochondrial membrane. TIM16 has a conserved J-like domain but lacks the HPD active motif found in true J-proteins. It stabilizes the active conformation of PAM18 and modulates the activity of the import motor. Mutations in this protein are associated with severe mitochondrial dysfunction, including some forms of skeletal dysplasia, and its dysregulation has been reported in several cancer types. PAM16 is essential for mitochondrial biogenesis and cellular energy metabolism; thus, it is not currently considered a druggable therapeutic target, but it is of high significance in basic mitochondrial biology and disease pathogenesis[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit TIM16 (PAM16).